Skip to content

Substance Use Screening Among Drug User

Screening and Brief Interventions for Substance Use in Primary Medical Institution

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02951858
Enrollment
218
Registered
2016-11-01
Start date
2017-01-31
Completion date
Unknown
Last updated
2016-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Use

Keywords

Alcohol,Smoking,and Substance Use Involvement Screening Test, Brief Intervention, Substance Use, Primary Medical and Health Care Institution

Brief summary

The purpose of this research is to improve the ability of primary medical staffs in screening and intervention for alcohol, benzodiazepines, and other illicit drug use.

Detailed description

In order to reduce the social and personal harm caused by drugs, it is urgent to strengthen the ability of the primary health institutions in screening and intervention the addictive substances use. Firstly, the investigators will invite 10 primary medical staffs and 10 experts in addition to revise the manual of Alcohol, Smoking, and Substance Use Involvement Screening Test (ASSIST) and Brief Intervention (BI). Then, the investigators will recruit 100 medical staffs to participate the training of ASSIST and BI. Secondly, the researcher will investigate the effects of BI technology in reducing the use of addictive substances, improve the addiction related knowledge of patients through randomized controlled study. Finally, the investigators will collect the research information, revise the manual, and promote the training.

Interventions

BEHAVIORALIntervention Group

The medical staffs who received the training will use the manual of brief intervention to deliver BI and other materials about the harm of substance use.

BEHAVIORALControl Group

The participants only receive the materials about the harm of substance use.

Sponsors

Shanghai Mental Health Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

1. aged 18-60 years; 2. the patient to the community medical institutions; 3. ASSIST score is in 12-27, in a moderate risk; 4. voluntary to participate; 5. to agree to complete baseline interviews and follow-up studies.

Exclusion criteria

1. unable to complete the questionnaire; 2. serious physical illness, action inconvenience.

Design outcomes

Primary

MeasureTime frameDescription
Risk Behaviors measured by ASSIST questionnaire1 monthRisk Behaviors will be measured by ASSIST questionnaire.
Knowledge related to Substance Use measured by Knowledge related to Addiction questionnaire1 monthKnowledge related to substance use will be measured by Knowledge related to Addiction questionnaire.
Motivation measured by Pre-treatment Readiness Scale1 monthMotivation will be measured by Pre-treatment Readiness Scale (PRS).

Secondary

MeasureTime frameDescription
Depression measured by Self-Rating Depression Scale1 monththe change of depression will be measured by Self-Rating Depression Scale (SDS).
Anxiety measured by Self-Rating Anxiety Scale1 monththe change of anxiety will be measured by Self-Rating Anxiety Scale (SAS).
Self-esteem measured by Self-esteem questionnaire1 monththe change of self-esteem will be measured by Self-esteem questionnaire.

Contacts

Primary ContactJiang Du, M.D
dujiangdou@163.com18017311220

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026